News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Introgen Therapeutics, Inc. (INGN) Announces Resignation of David G. Nance from Board of Directors



3/12/2009 9:21:26 AM

AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. today announced that David G. Nance has resigned from the company’s board of directors, effective immediately. Mr. Nance, who had served as Introgen’s chairman, also resigned from the boards of Introgen Technical Services, Inc. (ITS), and the company’s consolidated subsidiaries, with the exception of Gendux AB. Mr. Nance will remain a director for Gendux, Introgen’s wholly-owned subsidiary based in Sweden, until further notice.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES